|
|
|
Volumn 2, Issue 2, 2004, Pages 115-121
|
|
The role of FDG-PET imaging in the management of lymphoma.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIAGNOSTIC AGENT;
FLUORINE;
FLUORODEOXYGLUCOSE F 18;
GALLIUM;
RADIOPHARMACEUTICAL AGENT;
BONE MARROW;
CANCER STAGING;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE MANAGEMENT;
HUMAN;
LYMPHOMA;
METHODOLOGY;
NONHODGKIN LYMPHOMA;
PATHOLOGY;
POSITRON EMISSION TOMOGRAPHY;
PREDICTION AND FORECASTING;
PROGNOSIS;
RADIOGRAPHY;
RECURRENT DISEASE;
REVIEW;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
THREE DIMENSIONAL IMAGING;
TREATMENT OUTCOME;
BONE MARROW;
CLINICAL TRIALS;
DISEASE MANAGEMENT;
FLUORINE RADIOISOTOPES;
FLUORODEOXYGLUCOSE F18;
GALLIUM RADIOISOTOPES;
HUMANS;
IMAGING, THREE-DIMENSIONAL;
LYMPHOMA;
LYMPHOMA, HIGH-GRADE;
LYMPHOMA, LOW-GRADE;
NEOPLASM STAGING;
POSITRON-EMISSION TOMOGRAPHY;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RADIOPHARMACEUTICALS;
RECURRENCE;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
|
|
EID: 33748159800
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (30)
|
|
References (59)
|
